Concord Wealth Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.9K Buy
+123
New +$8.09K ﹤0.01% 603
2026
Q1
Sell
-123
Closed -$10.1K 418
2025
Q4
$10.1K Buy
123
+84
+215% +$6.54K ﹤0.01% 537
2025
Q3
$2.93K Sell
39
-84
-68% -$6.26K ﹤0.01% 683
2025
Q2
$9.13K Buy
123
+63
+105% +$4.39K ﹤0.01% 553
2025
Q1
$4.85K Sell
60
-35
-37% -$3.01K ﹤0.01% 589
2024
Q4
$7.44K Sell
95
-114
-55% -$9.69K ﹤0.01% 552
2024
Q3
$19.6K Buy
209
+82
+65% +$6.88K ﹤0.01% 473
2024
Q2
$9.91K Sell
127
-78
-38% -$6.36K ﹤0.01% 509
2024
Q1
$18.7K Sell
205
-142
-41% -$11.8K ﹤0.01% 496
2023
Q4
$26.9K Buy
347
+21
+6% +$1.47K 0.01% 442
2023
Q3
$22.2K Buy
326
+55
+20% +$4K ﹤0.01% 493
2023
Q2
$22K Buy
271
+24
+10% +$1.92K ﹤0.01% 492
2023
Q1
$20.3K Buy
+247
New +$17.6K 0.01% 491

Other funds holding GEHC

Concord Wealth Partners's GEHC Position: Q2 2026 in Review

Concord Wealth Partners opened a new position in GE HealthCare (GEHC) in Q2 2026: 123 shares worth $7.9K. The stake represents ﹤0.01% of the portfolio and ranks #603 among its holdings. This is a return to the name: Concord Wealth Partners previously reported a position in GEHC as recently as Q4 2025.

Concord Wealth Partners first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $26.9K in Q4 2023. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Concord Wealth Partners held 123 shares of GE HealthCare worth $7.9K as of Q2 2026.
  • GE HealthCare was a new Concord Wealth Partners position in Q2 2026.
  • GE HealthCare made up ﹤0.01% of Concord Wealth Partners's portfolio in Q2 2026, its #603 holding.
  • Concord Wealth Partners first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Concord Wealth Partners's GE HealthCare position peaked at $26.9K in Q4 2023.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Concord Wealth Partners's 13F filing for Q2 2026, filed 27 Jul 2026.